Clinical Trial

Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to do follow-up testing on the safety and tolerability of an experimental (not FDA approved) medication. This study is seeking non-illicit drug using adults to test the medication. Results of this study will help us to develop future studies to test the medication with people who use substances. This research is supported by and included in the NIH HEAL Initiative (https://heal.nih.gov/).
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-08-12
Trial Details
NCT Number NCT07531316
Lead Sponsor Virginia Commonwealth University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Healthy Controls
Enrollment 60 participants
Start Date 2026-07-15
Primary Completion 2031-12-20 (estimated)
Study Completion 2031-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-11